P323 Sustained therapeutic benefit of vedolizumab throughout 1 year in ulcerative colitis in GEMINI I, a randomized, placebo-controlled, double-blind, multicenter trial

✍ Scribed by Sandborn, W.; Sands, B.; Rutgeerts, P.; Sankoh, S.; Rosario, M.; Milch, C.; Fox, I.

• Book ID: 123465337
• Publisher: Oxford University Press
• Year: 2013
• Tongue: English
• Weight: 232 KB
• Volume: 7
• Category: Article
• ISSN: 1873-9946
• DOI: 10.1016/S1873-9946(13)60344-X